LABORATORY REPORT

Name : LABHUBEN VASHRAMBHAI VAGHANI Sex/Age : Female / 50 Years Case ID : 40903623147

Ref. By : Dis. At : Pt. ID :
Bill. Loc. : OM PATHOLOGY LAB SARTHANA SURAT Pt. Loc :
Reg Date and Time : 27-Sep-2024 13:57 Sample Type : Mobile No. :
Sample Date and Time : 27-Sep-2024 13:57 Sample Coll. By : non NAL Ref Id1 :
Report Date and Time : Acc. Remarks : Ref Id2 :

Abnormal Result(s) Summary

Test Name Result Value Unit Reference Range
Pyogenic Culture And Sensitivity For Bacteria
Organism Klebsiella pneumoniae
Abnormal Result(s) Summary End

Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh ,A-Abnormal)

Printed On : 29-Sep-2024 14:10

Page 1 of 5
 LABORATORY REPORT

Name : LABHUBEN VASHRAMBHAI VAGHANI Sex/Age : Female / 50 Years Case ID : 40903623147

Ref. By : Dis. At : Pt. ID :
Bill. Loc. : OM PATHOLOGY LAB SARTHANA SURAT Pt. Loc :
Reg Date and Time : 27-Sep-2024 13:57 Sample Type : Urine Mobile No. :
Sample Date and Time : 27-Sep-2024 13:57 Sample Coll. By : non NAL Ref Id1 :
Report Date and Time : 29-Sep-2024 14:03 Acc. Remarks : Ref Id2 :

TEST RESULTS

Culture And Sensitivity For Bacteria

Specimen URINE
Gram Stain The smear shows few pus cells and many gram negative bacilli.
Z.N. Stain A.F.B. Not Detected
Organism Klebsiella pneumoniae
Colony Count > 1,00,000 cfu/ml
Note For Enterobacterales, CLSI 2024 does not have interpretive disk
diffusion criteria for Colistin or Polymyxin B. When requested MIC
interpretive criteria of EUCAST 2024 is used to report Colistin or
Polymyxin B by Microbroth dilution method.

As per CLSI M100-ED34, For Colistin only broth microdilution,

broth disk elution method and agar dilution MIC methods are
approved. Disk diffusion and gradient diffusion methods should
not be performed.

For Polymyxin-B, Broth Microdilution is the only approved method.

Disk diffusion and gradient diffusion methods should not be
performed.

Interpretive criteria for Tigecycline is not available in CLSI

2024(M100-ED34 ). EUCAST disk diffusion criteria is available
only for Escherichia coli. When requested MIC interpretive criteria
of EUCAST is used to report Tigecycline.

Criteria for Cefoperazone-sulbactam, Cefotaxime-sulbactam and

Cefepime-tazobactam are not available in CLSI 2024(M100-ED34)
or EUCAST. These drugs are reported by disk diffusion CLSI
criteria of native drug.

Current EUCAST disk diffusion criteria are being used for

Moxifloxacin.

MIC on Automated system (VITEK-2) is recommended.

Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh ,A-Abnormal)

Dr. Manthan Shah Printed On : 29-Sep-2024 14:10

M.D. (Microbiology)
Page 2 of 5
 LABORATORY REPORT

Name : LABHUBEN VASHRAMBHAI VAGHANI Sex/Age : Female / 50 Years Case ID : 40903623147

Ref. By : Dis. At : Pt. ID :
Bill. Loc. : OM PATHOLOGY LAB SARTHANA SURAT Pt. Loc :
Reg Date and Time : 27-Sep-2024 13:57 Sample Type : Urine Mobile No. :
Sample Date and Time : 27-Sep-2024 13:57 Sample Coll. By : non NAL Ref Id1 :
Report Date and Time : 29-Sep-2024 14:03 Acc. Remarks : Ref Id2 :

_________________________________________________________________________________________________________________________
Note:
• E-coli and Pseudomonas species have a typical character of changing their drug sensitivity pattern for their survival through their Plasmids. Therefore a repeat in
culture and sensitivity after one week is warranted.
• In case of Growth of Candida on a bacterial medium,colony count should be considered / Expected to be higher on fungal medium.
Ref. : CLSI M100 guidelines

Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh ,A-Abnormal)

Dr. Manthan Shah Printed On : 29-Sep-2024 14:10

M.D. (Microbiology)
Page 3 of 5
 LABORATORY REPORT

Name : LABHUBEN VASHRAMBHAI VAGHANI Sex/Age : Female / 50 Years Case ID : 40903623147

Ref. By : Dis. At : Pt. ID :
Bill. Loc. : OM PATHOLOGY LAB SARTHANA SURAT Pt. Loc :
Reg Date and Time : 27-Sep-2024 13:57 Sample Type : Urine Mobile No. :
Sample Date and Time : 27-Sep-2024 13:57 Sample Coll. By : non NAL Ref Id1 :
Report Date and Time : 29-Sep-2024 14:04 Acc. Remarks : Ref Id2 :

Specimen : Urine
Organism : Klebsiella pneumoniae
Antibiotics Sensitivity Antibiotics Sensitivity Antibiotics Sensitivity

Ampicillin R Cefixime S Minocycline R

Piperacillin R Ceftazidime S Erythromycin R
Ticarcillin R Cefoperazone S Azithromycin R
Imipenem S Cefoperazone + Sulbactam S Clarithromycin R
Meropenem S Cefotaxime + Sulbactam S Clindamycin R
Doripenem S Cefepime S Vancomycin R
Ertapenem S Cefepime + Tazobactam S Teicoplanin R
Aztreonam S Amikacin S Linezolid R
Ampicillin+ Sulbactam S Gentamicin S Trimethoprim R
Amoxycillin + Clavulanic Acid S Netilmicin S Comp. Sulfonamides R
Piperacillin + Tazobactam S Tobramycin S Co-Trimoxazole R
Ticarcillin + Clavulanic Acid S Nalidixic Acid R Nitrofurantoin S
Cefazolin R Ciprofloxacin R Polymyxin-B -
Cephalexin R Ofloxacin R Colistin -
Cefuroxime R Levofloxacin R Tigecycline -
Cefoxitin R Norfloxacin R Chloramphenicol R
Cefotaxime S Lomefloxacin R Fosfomycin S
Ceftriaxone S Tetracycline R
Doxycycline R

------------------ End Of Report ------------------

# For test performed on specimens received or collected from non-NSRL locations, it is presumed that the specimen belongs to the patient named
or identified as labeled on the container/test request and such verification has been carried out at the point generation of the said specimen by the
sender. NSRL will be responsible Only for the analytical part of test carried out. All other responsibility will be of referring Laboratory.

Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh ,A-Abnormal)

Dr. Manthan Shah Printed On : 29-Sep-2024 14:10

M.D. (Microbiology)
Page 4 of 5
 LABORATORY REPORT

Name : LABHUBEN VASHRAMBHAI VAGHANI Sex/Age : Female / 50 Years Case ID : 40903623147

Ref. By : Dis. At : Pt. ID :
Bill. Loc. : OM PATHOLOGY LAB SARTHANA SURAT Pt. Loc :
Reg Date and Time : 27-Sep-2024 13:57 Sample Type : Urine Mobile No. :
Sample Date and Time : 27-Sep-2024 13:57 Sample Coll. By : non NAL Ref Id1 :
Report Date and Time : 29-Sep-2024 14:04 Acc. Remarks : Ref Id2 :

Note : Reported as per CLSI guidelines. ( S-Sensitive, I-Intermediate, R- Resistant , S-DD - Sensitive Dose Dependant)

Note:(LL-VeryLow,L-Low,H-High,HH-VeryHigh ,A-Abnormal)

Dr. Manthan Shah Printed On : 29-Sep-2024 14:10

M.D. (Microbiology)
Page 5 of 5